about
Investigating synapse formation and function using human pluripotent stem cell-derived neuronsModelling schizophrenia using human induced pluripotent stem cells.Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screenNoncoding RNAs and neurobehavioral mechanisms in psychiatric diseaseHigh-efficient generation of induced pluripotent stem cells from human astrocytesCreating Patient-Specific Neural Cells for the In Vitro Study of Brain Disorders.Mosaic copy number variation in human neuronsModeling psychiatric disorders at the cellular and network levelsAll beta cells contribute equally to islet growth and maintenance.Inhibition of STEP61 ameliorates deficits in mouse and hiPSC-based schizophrenia models.Reprogramming of pancreatic beta cells into induced pluripotent stem cellsSlow and steady is the key to beta-cell replication.Roles of heat shock factor 1 in neuronal response to fetal environmental risks and its relevance to brain disorders.Rapid cellular turnover in adipose tissueConcise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia.Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia.Human iPSC neurons display activity-dependent neurotransmitter secretion: aberrant catecholamine levels in schizophrenia neurons.Evolving toward a human-cell based and multiscale approach to drug discovery for CNS disorders.A role for noncoding variation in schizophreniaA guide to generating and using hiPSC derived NPCs for the study of neurological diseasesModeling psychiatric disorders through reprogramming.Altered WNT Signaling in Human Induced Pluripotent Stem Cell Neural Progenitor Cells Derived from Four Schizophrenia Patients.The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder.Characterization of molecular and cellular phenotypes associated with a heterozygous CNTNAP2 deletion using patient-derived hiPSC neural cells.Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristicsDysregulation of miRNA-9 in a Subset of Schizophrenia Patient-Derived Neural Progenitor CellsRapid Ngn2-induction of excitatory neurons from hiPSC-derived neural progenitor cells.Increased abundance of translation machinery in stem cell-derived neural progenitor cells from four schizophrenia patients.Gene expression elucidates functional impact of polygenic risk for schizophrenia.Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.Altered proliferation and networks in neural cells derived from idiopathic autistic individuals.Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises.Neural stem and progenitor cells in health and disease.Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells.Modeling hippocampal neurogenesis using human pluripotent stem cells.Using hiPSCs to model neuropsychiatric copy number variations (CNVs) has potential to reveal underlying disease mechanisms.Spatial genome organization and cognition.Application of CRISPR/Cas9 to the study of brain development and neuropsychiatric disease.Brief report: efficient generation of hematopoietic precursors and progenitors from human pluripotent stem cell lines.
P50
Q24338661-159DD553-5159-4646-B766-F3A3127D6FFFQ24633007-5C80BC76-D261-4C41-8DFC-AAE373C5E865Q26747306-BBD6ABD7-009C-4257-8D20-5C3B6DA5AB19Q26851626-B42429E1-91DD-44EA-A994-D775DD1FD859Q28744346-B91E9E6E-473B-4870-B2EA-210E524E7C9BQ30278015-AACE3C18-AF18-4C40-90F3-8F72AE322651Q30409886-79E9C28E-20A0-4ED3-99CA-0688F8973E01Q30446669-3BCC5F31-51B9-43C6-8098-AD61879163DEQ33286067-E96DE3E6-54B7-4407-BE2B-289E11AF99DAQ33574936-2AE5AEE8-6147-41D2-B254-CCC8F47C7E8CQ33641629-A0936EB2-E490-492C-B87A-B55524D470FCQ33647542-5C27589B-764A-4480-BAA2-98772F705236Q33733359-BC8866F4-1F72-4B88-B5A1-E72EC50E90E2Q33847015-862C45B9-6256-4AD0-BAB4-BCFB052518EBQ34051160-751F02A1-5546-4177-A912-175F0A41CFA8Q34276729-06B4A4ED-EF40-4C84-BF21-51E1A86F58D2Q34469459-CE2DFFCA-8291-47C8-931E-978BCC8BF8D1Q34608239-AB7E8A69-5E65-4C36-8BE2-7E7E903F4B92Q34632245-CE988E91-CFEA-477D-B571-5A34F708BDABQ35162311-8AA395B9-18A4-45DD-B308-8E929CE0DF7FQ35665016-1739E0CB-1D7C-4B23-BA45-9BCF48955E96Q35904650-A62BFE33-4095-4B18-9BA2-33D7CCB9D81BQ36010076-B6B2867C-6FEB-42D0-B52C-B94CE8FC7158Q36546243-54713A8F-7CFF-49F2-B0C3-F6E3848F4AFDQ36680149-A0980D89-8561-443D-AFBE-F11DCB54E9B0Q36858621-A1294F9B-CDA1-47FF-A1B6-88CD621BB6FEQ36869455-10D973C6-67D6-4EAF-A51B-5FB2D4CD6CFDQ36880318-65B9ADE6-5E5F-4F68-BA85-C132E4C4DC27Q37058606-5213DC61-2996-48D1-9389-1A3BD8C0D159Q37372402-1695E6B5-1985-4924-BC3F-A07B114076EAQ37383525-C6636BCE-E5BD-4ECF-B9EF-2D52F781AB39Q37562213-06A301EA-A841-4C60-8B50-B68B5B701971Q37914472-E1613A28-C786-4A9E-9C92-FA72C838B759Q38143704-13096A70-0EDE-4C9E-AF78-5F647C3371B6Q38170728-069D3624-4FDB-4AF3-B34A-574C2D6FF60DQ38460557-23C1D8A1-AE40-4159-BC25-8601079F5427Q38637625-ACA16B8F-77A7-48C7-BBBC-656C9E2FB578Q38973220-546F5CC6-94A2-40C9-80FD-98A58C0611DCQ39333331-61C5BBD5-3F94-4BFC-9D59-080C103BD77CQ40258263-40F16FA0-65D4-4580-935E-61052222460B
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Kristen J Brennand
@nl
Kristen J Brennand
@sl
Kristen J. Brennand
@en
Kristen J. Brennand
@es
type
label
Kristen J Brennand
@nl
Kristen J Brennand
@sl
Kristen J. Brennand
@en
Kristen J. Brennand
@es
prefLabel
Kristen J Brennand
@nl
Kristen J Brennand
@sl
Kristen J. Brennand
@en
Kristen J. Brennand
@es
P1053
J-8704-2012
P106
P1153
17343536100
P21
P31
P3829
P496
0000-0003-0993-5956